La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Medico Intercontinental Gestione

Gestione criteri di controllo 2/4

Medico Intercontinental's Il CEO è Dilipkumar Shah, nominato in May2019, ha un mandato di 5.25 anni. possiede direttamente 10.74% delle azioni della società, per un valore di ₹ 51.79M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.2 anni e 5.3 anni.

Informazioni chiave

Dilipkumar Shah

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	5.3yrs
Proprietà del CEO	10.7%
Durata media del management	5.2yrs
Durata media del Consiglio di amministrazione	5.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Dilipkumar Shah

5.3yrs

Mandato

Mr. Dilipkumar Bhogilal Shah has been Chief Executive Officer of Medico Intercontinental Limited since May 29, 2019. Mr. Shah has vast experience of more than 40 years in Pharma Business.

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Samir Shah	MD & Director	no data	₹2.40m	44.33% ₹ 212.1m
Dilipkumar Shah	Chief Executive Officer	5.3yrs	Nessun dato	10.74% ₹ 51.4m
Jay Shah	Chief Financial Officer	5yrs	₹719.65k	0.51% ₹ 2.4m
Puneeta Sharma	Company Secretary & Compliance Officer	5.2yrs	₹438.19k	Nessun dato

5.2yrs

Durata media

Gestione esperta: Il team dirigenziale di 539938 è esperto e expertise (durata media dell'incarico 5.2 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Samir Shah	MD & Director	6yrs	₹2.40m	44.33% ₹ 212.1m
Tanvi Shah	Non-Executive Chairman	6yrs	Nessun dato	Nessun dato
Ankur Dave	Independent Director	5.4yrs	Nessun dato	Nessun dato
Swati Shah	Additional Non-Executive Director	5.3yrs	Nessun dato	Nessun dato
Priyank Sancheti	Independent Director	1.8yrs	Nessun dato	Nessun dato
Parshwa Shah	Additional Independent Director	less than a year	Nessun dato	Nessun dato

5.3yrs

Durata media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 539938 sono considerati esperti (durata media dell'incarico 5.3 anni).

Medico Intercontinental Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Medico Intercontinental Limited, Annual General Meeting, Sep 27, 2024

Less than half of directors are independent

Medico Intercontinental Limited Announces Resignation of Nikul Dipakbhai Shah as Independent Director

MD & Director recently bought ₹926k worth of stock

Medico Intercontinental Limited, Annual General Meeting, Jun 30, 2023

Medico Intercontinental Limited Appoints Priyank L Sancheti as an Additional Independent Director

Recent updates

First quarter 2025 earnings released: EPS: ₹1.08 (vs ₹0.94 in 1Q 2024)

Medico Intercontinental Limited, Annual General Meeting, Sep 27, 2024

Medico Intercontinental Limited to Report Q1, 2025 Results on Aug 13, 2024

Medico Intercontinental Limited to Report Q1, 2025 Results on Aug 13, 2024

Investor sentiment improves as stock rises 17%

Medico Intercontinental Limited to Report Q4, 2024 Results on May 25, 2024

Less than half of directors are independent

Medico Intercontinental Limited Announces Resignation of Nikul Dipakbhai Shah as Independent Director

Investor sentiment improves as stock rises 22%

Investor sentiment deteriorates as stock falls 15%

New major risk - Market cap size

Third quarter 2024 earnings released: EPS: ₹1.02 (vs ₹0.94 in 3Q 2023)

Investor sentiment deteriorates as stock falls 17%

Medico Intercontinental Limited to Report Q3, 2024 Results on Feb 14, 2024

Investor sentiment improves as stock rises 16%

MD & Director recently bought ₹926k worth of stock

Second quarter 2024 earnings released: EPS: ₹0.87 (vs ₹2.66 in 2Q 2023)

Medico Intercontinental Limited to Report Q1, 2024 Results on Aug 14, 2023

Medico Intercontinental Limited Approves Final Equity Dividend for the Financial Year 2022-23

Full year 2023 earnings released: EPS: ₹5.61 (vs ₹9.54 in FY 2022)

Medico Intercontinental Limited, Annual General Meeting, Jun 30, 2023

Medico Intercontinental Limited to Report Q4, 2023 Results on May 29, 2023

Investor sentiment improves as stock rises 25%

Third quarter 2023 earnings released: EPS: ₹0.94 (vs ₹2.30 in 3Q 2022)

Investor sentiment improves as stock rises 25%

Medico Intercontinental Limited to Report Q3, 2023 Results on Feb 14, 2023

Second quarter 2023 earnings released: EPS: ₹2.66 (vs ₹2.29 in 2Q 2022)

Medico Intercontinental Limited Appoints Priyank L Sancheti as an Additional Independent Director

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Medico Intercontinental Limited Approves Regularisation of Nikul Dipakbhai Shah as an Independent Director

Investor sentiment improved over the past week

Medico Intercontinental Limited announced that it expects to receive INR 249.787 million in funding

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Medico Intercontinental Limited to Report Q4, 2022 Results on May 28, 2022

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Less than half of directors are independent

Medico Intercontinental Limited Announces Resignation Mr. Hiren Ravindrabhai Shah as Independent Director

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

High number of new directors

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹7.93 (vs ₹7.25 in FY 2020)

Investor sentiment improved over the past week

New 90-day low: ₹35.00

Medico Intercontinental Limited to Report Nine Months, 2021 Results on Feb 12, 2021

New 90-day high: ₹54.35

Market bids up stock over the past week

New 90-day low: ₹28.00

Market pulls back on stock over the past week

Market pulls back on stock over the past week

First quarter earnings released

New 90-day high - ₹48.75

Medico Intercontinental Limited to Report Q1, 2021 Results on Sep 15, 2020

New 90-day high - ₹32.80

Medico Intercontinental Limited announced that it expects to receive INR 52.32025 million in funding

Medico Intercontinental Limited to Report Q4, 2020 Results on Jun 30, 2020

AMMINISTRATORE DELEGATO

Mandato

Gruppo dirigente

Durata media

Membri del Consiglio di amministrazione

Durata media